Evidence map›Paper›PMID 37243114›Full record

ArticleVaccines2023

COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated.

Franck Mboussou, Bridget Farham, Sheillah Nsasiirwe, Ajiri Atagbaza, Daniel Oyaole, Phionah Lynn Atuhebwe, Victor Alegana, Fred Osei-Sarpong, Ado Bwaka, Gilson Paluku and 5 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  4. Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Franck MboussouWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0002-9062-5084
Bridget FarhamWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0001-5463-0858
Sheillah NsasiirweWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Ajiri AtagbazaWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0002-3123-6636
Daniel OyaoleWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0002-8397-8930
Phionah Lynn AtuhebweWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Victor AleganaWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Fred Osei-SarpongWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Ado BwakaWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Gilson PalukuWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Amos PetuWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Oniovo Efe-AlutaWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Akpaka KaluWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Magaran Monzon BagayokoWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Benido ImpoumaWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
World Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

This study summarizes progress made in rolling out COVID-19 vaccinations in the African region in 2022, and analyzes factors associated with vaccination coverage. Data on vaccine uptake reported to the World Health Organization (WHO) Regional Office for Africa by Member States between January 2021 and December 2022, as well as publicly available health and socio-economic data, were used. A negative binomial regression was performed to analyze factors associated with vaccination coverage in 2022. As of the end of 2022, 308.1 million people had completed the primary vaccination series, representing 26.4% of the region's population, compared to 6.3% at the end of 2021. The percentage of health workers with complete primary series was 40.9%. Having carried out at least one high volume mass vaccination campaign in 2022 was associated with high vaccination coverage (β = 0.91,

Indexed as

African regioncoverageCOVID-19 vaccines

Identifiers

PMID37243114
PMCPMC10223522
OpenAlexW4377288925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.